Whitcomb David C
Medicine, Cell Biology & Physiology, and Human Genetics, University of Pittsburgh & University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania
-related hereditary pancreatitis (HP) is characterized by episodes of acute pancreatitis (AP) and recurrent acute pancreatitis (RAP: >1 episode of AP), with frequent progression to chronic pancreatitis (CP). Manifestations of AP can range from vague abdominal pain lasting one to three days to severe abdominal pain lasting days to weeks and requiring hospitalization.
DIAGNOSIS/TESTING: The diagnosis of -related HP is established in a proband with episodes of AP, RAP, and/or CP and a heterozygous pathogenic gain-of-function variant in identified by molecular genetic testing. Note: Because of reduced penetrance, identification of a disease-associated variant in an asymptomatic individual is not sufficient for a clinical diagnosis. High-penetrance pathogenic variants include p.Asn29Ile and p.Arg122His, and lower-penetrance pathogenic variants include p.Arg16Val, Asp22Gly, p.Lys23Arg, p.Asn29Thr, and p.Arg122Cys. Other pathogenic and risk variants are recognized; these latter variants typically require additional risk factors to cause disease and do not cause autosomal dominant hereditary pancreatitis.
AP episodes are treated with rapid assessment of severity and fluid resuscitation as needed. Individuals with -related HP should be counseled not to delay in being assessed for AP because hypovolemia and shock leads to serious organ dysfunction and failure. For CP, continue strategies to prevent RAP attacks. Antioxidants may have some benefit. Pancreatic enzyme replacement therapy to improve digestion in those with pancreatic insufficiency and bloating, steatorrhea, diarrhea, unexplained weight loss, and/or micronutrient deficiencies (e.g., vitamins A, D, B). Treatment of glucose intolerance with a regimen typically including metformin and insulin. Management of pain can be challenging but should begin with medical therapy, with endoscopic therapies for obstructions and surgery for more severe pain, including total pancreatectomy with islet autotransplantation, an irreversible procedure with obligate side effects, in select individuals with severe CP. Avoid smoking and alcohol abuse. A healthy diet that is low in red meat, with multiple small meals if it improves symptoms, good hydration (especially during exercise), vitamins, and antioxidants is recommended. Some individuals report that moderate exercise helps control episodes of pain and reduces pain severity. Referral to a surveillance program. Alcohol and tobacco use; dehydration; physical and emotional stress. Molecular genetic testing for the familial pathogenic variant is appropriate in order to identify as early as possible those who would benefit from education regarding lifestyle choices to decrease the risk of pancreatitis and pancreatic cancer and provide screening for pancreatic exocrine and endocrine dysfunction.
HP caused by gain-of-function pathogenic variants is inherited in an autosomal dominant manner. Many individuals diagnosed with -related HP have an affected parent; some individuals have the disorder as the result of a pathogenic variant. Each child of an individual with -related HP has a 50% chance of inheriting the pathogenic variant. Once the pathogenic variant has been identified in an affected family member, predictive testing for at-risk relatives and prenatal/preimplantation genetic testing for -related HP are possible.
[相关基因名称]相关性遗传性胰腺炎(HP)的特点是出现急性胰腺炎(AP)发作和复发性急性胰腺炎(RAP:AP发作超过1次),并经常进展为慢性胰腺炎(CP)。AP的表现范围从持续1至3天的模糊腹痛到持续数天至数周且需要住院治疗的严重腹痛。
诊断/检测:在一名先证者中,若其出现AP、RAP和/或CP发作,且通过分子基因检测鉴定出[相关基因名称]存在杂合致病性功能获得性变异,则可确立[相关基因名称]相关性HP的诊断。注意:由于外显率降低,在无症状个体中鉴定出与疾病相关的[相关基因名称]变异不足以进行临床诊断。高外显率致病性变异包括p.Asn29Ile和p.Arg122His,低外显率致病性变异包括p.Arg16Val、Asp22Gly、p.Lys23Arg、p.Asn29Thr和p.Arg122Cys。还识别出其他[相关基因名称]致病性和风险变异;这些后一类变异通常需要额外的风险因素才会导致疾病,且不会引起常染色体显性遗传性胰腺炎。
对AP发作进行快速严重程度评估,并根据需要进行液体复苏治疗。应建议[相关基因名称]相关性HP患者一旦出现AP不要拖延评估,因为低血容量和休克会导致严重器官功能障碍和衰竭。对于CP,继续采取预防RAP发作的策略。抗氧化剂可能有一定益处。对于有胰腺功能不全、腹胀、脂肪泻、腹泻、不明原因体重减轻和/或微量营养素缺乏(如维生素A、D、B)的患者,采用胰酶替代疗法改善消化。采用通常包括二甲双胍和胰岛素的方案治疗糖耐量异常。疼痛管理可能具有挑战性,但应首先采用药物治疗,对于梗阻采用内镜治疗,对于更严重的疼痛采用手术治疗,包括在某些严重CP患者中进行胰岛自体移植的全胰切除术,这是一种具有必然副作用的不可逆手术。避免吸烟和酗酒。建议采用低红肉饮食、如果症状改善则少食多餐、充足补水(尤其是运动期间)、补充维生素和抗氧化剂的健康饮食。一些患者报告适度运动有助于控制疼痛发作并减轻疼痛严重程度。转诊至监测项目。酒精和烟草使用;脱水;身体和情绪压力。为了尽早识别那些将从关于生活方式选择的教育中受益以降低胰腺炎和胰腺癌风险并对胰腺外分泌和内分泌功能障碍进行筛查的个体,对家族性[相关基因名称]致病性变异进行分子基因检测是合适的。
由功能获得性[相关基因名称]致病性变异引起的HP以常染色体显性方式遗传。许多被诊断为[相关基因名称]相关性HP的个体有患病的父母;一些个体因[相关基因名称]致病性变异而患病。[相关基因名称]相关性HP患者的每个孩子有50%的机会继承致病性变异。一旦在患病家庭成员中鉴定出[相关基因名称]致病性变异,就可以对有风险的亲属进行预测性检测,并对[相关基因名称]相关性HP进行产前/植入前基因检测。